Elutia (ELUT) Earnings Date & Reports

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ELUT is expected to report earnings to fall 7.69% to -23 cents per share on May 07

Q1'25

Est.

$-0.24

Q4'24

Missed

by $0.02

Q3'24

Beat

by $0.11

Q2'24

Missed

by $0.78

Q1'24

Missed

by $0.43

The last earnings report on March 06 showed earnings per share of -25 cents, missing the estimate of -23 cents. With 44.60K shares outstanding, the current market capitalization sits at 76.46M.

View a ticker or compare two or three

Compare

ELUT